Yan-Ping Ren1, Ming-Juan Zhang2, Ting Zhang1, Ruo-Wen Huang1. 1. Department of Geriatric-Cardiovascular Diseases, The First Affiliated Hospital of Medical College in Xi'an Jiaotong University Xi'an 710061, China. 2. Department of Cardiology, The Second Affiliated Hospital of Medical College in Xi'an Jiaotong University Xi'an 710004, China.
Abstract
PURPOSE: To elucidate the effect of ouabain on the regulation of proliferation and apoptosis of HUVECs and involvement of different Na(+)-K(+)-ATPase α-subunits and NF-κB. METHODS: HUVECs were isolated by collagenase perfusion, and MTT assays and cell cycle analysis were performed to study proliferation. NF-κB expression and function were examined by immunohistochemical staining and western blotting. Na(+)-K(+)-ATPase activity was determined by measuring released ouabain inhibitable inorganic phosphate (Pi). The expression of different α-subunits was investigated by real RT-PCR, western blotting and cell immunofluorescence. RESULTS: 0.3 nM ouabain treatment for 0.5 h triggered the proliferation of HUVECs, peaking at 1-2 h. At 1.8 nM for 0.5 h, ouabain induced an increase of cell proliferation for a short time, and then triggered a decrease after 1 h. Cell cycle analysis show that 37% of HUVECs were in G2/M phase of the cell cycle following incubation with 1.8 nM ouabain, compared with 18% with 0.3 nM ouabain. NF-κB activity was assessed by western blot analysis of IκB expression, which was significantly reduced with 0.3 nM ouabain treatment; there was no different between 1.8 nM ouabain treatment and untreated cells. Na(+)-K(+)-ATPase activity in HUVECs was markedly reduced after treatment with 0.3 nM and 1.8 nM ouabain. Real RT-PCR and western blotting indicated that Na(+)-K(+)-ATPase α1-subunit mRNA expression levels increased after 0.3 nM ouabain treatment and decreased after 1.8 nM ouabain treatment. However, α2- and α3-subunit mRNA decreased after 0.3 nM ouabain treatment and increased after 1.8 nM ouabain treatment. CONCLUSION: Ouabain at different concentrations caused dual effects on proliferation and apoptosis in HUVECs.
PURPOSE: To elucidate the effect of ouabain on the regulation of proliferation and apoptosis of HUVECs and involvement of different Na(+)-K(+)-ATPase α-subunits and NF-κB. METHODS: HUVECs were isolated by collagenase perfusion, and MTT assays and cell cycle analysis were performed to study proliferation. NF-κB expression and function were examined by immunohistochemical staining and western blotting. Na(+)-K(+)-ATPase activity was determined by measuring released ouabain inhibitable inorganic phosphate (Pi). The expression of different α-subunits was investigated by real RT-PCR, western blotting and cell immunofluorescence. RESULTS: 0.3 nM ouabain treatment for 0.5 h triggered the proliferation of HUVECs, peaking at 1-2 h. At 1.8 nM for 0.5 h, ouabain induced an increase of cell proliferation for a short time, and then triggered a decrease after 1 h. Cell cycle analysis show that 37% of HUVECs were in G2/M phase of the cell cycle following incubation with 1.8 nM ouabain, compared with 18% with 0.3 nM ouabain. NF-κB activity was assessed by western blot analysis of IκB expression, which was significantly reduced with 0.3 nM ouabain treatment; there was no different between 1.8 nM ouabain treatment and untreated cells. Na(+)-K(+)-ATPase activity in HUVECs was markedly reduced after treatment with 0.3 nM and 1.8 nM ouabain. Real RT-PCR and western blotting indicated that Na(+)-K(+)-ATPase α1-subunit mRNA expression levels increased after 0.3 nM ouabain treatment and decreased after 1.8 nM ouabain treatment. However, α2- and α3-subunit mRNA decreased after 0.3 nM ouabain treatment and increased after 1.8 nM ouabain treatment. CONCLUSION:Ouabain at different concentrations caused dual effects on proliferation and apoptosis in HUVECs.
Authors: E M Kawamoto; L S Lima; C D Munhoz; L M Yshii; P F Kinoshita; F G Amara; R R F Pestana; A M M Orellana; J Cipolla-Neto; L R G Britto; M C W Avellar; L V Rossoni; C Scavone Journal: J Neurosci Res Date: 2011-10-18 Impact factor: 4.164
Authors: J M Hamlyn; M P Blaustein; S Bova; D W DuCharme; D W Harris; F Mandel; W R Mathews; J H Ludens Journal: Proc Natl Acad Sci U S A Date: 1991-07-15 Impact factor: 11.205
Authors: Tara N Rindler; Valerie M Lasko; Michelle L Nieman; Motoi Okada; John N Lorenz; Jerry B Lingrel Journal: Am J Physiol Heart Circ Physiol Date: 2013-02-22 Impact factor: 4.733
Authors: Rajvir Singh; Gregory Millman; Eric Turin; Lucasz Polisiakeiwicz; Brian Lee; Francesca Gatti; Jonas Berge; Emily Smith; John Rutter; Chris Sumski; W Tyler Winders; Abbas Samadi; C George Carlson Journal: J Neurol Sci Date: 2009-07-24 Impact factor: 3.181
Authors: Elizaveta A Klimanova; Artem M Tverskoi; Svetlana V Koltsova; Svetlana V Sidorenko; Olga D Lopina; Johanne Tremblay; Pavel Hamet; Leonid V Kapilevich; Sergei N Orlov Journal: Sci Rep Date: 2017-03-27 Impact factor: 4.379